Eyes Vision

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC39-3

DiraChart Clinical Reference
Protected section 3 of 25
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 3 of 25PreviousNext

2. What the clinician must assess

A complete functional eye and vision assessment addresses each of the following as indicated by the patient’s condition and orders, and compares each finding to baseline.

  • Functional vision — the ability to read a medication label, identify objects, and navigate the home, with corrective lenses as used.
  • Reported visual change — blurring, double vision, floaters, flashes, a curtain or shadow, pain, or loss, and its onset and pattern.
  • External eye — the lids, lashes, conjunctiva, and sclera for redness, discharge, swelling, or lesions.
  • Pupils — gross size, equality, and reactivity to light (detailed cranial-nerve testing is documented in Neurological).
  • Ocular pain — its character and any associated halos, nausea, or vomiting.
  • Corrective lenses and low-vision aids — availability, condition, and use.
  • Ocular-medication regimen — the drops or ointments ordered and the patient’s administration technique.
  • Diabetic and hypertensive ocular risk — the need for interval retinopathy surveillance and the date of the last eye exam (cross-reference the Diabetes and Hypertension overlays).
  • Vision-related safety — the contribution of reduced vision to fall and medication-error risk (cross-reference Safety).
  • Post-operative ocular status where applicable — after cataract or other eye surgery, the activity precautions and drop schedule.
Section NavigationPart 3 of 25PreviousNext